Normal view MARC view ISBD view

Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer.

Jung, K

Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer. [electronic resource] - Clinical chemistry Nov 2001 - 2061-3 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

ISSN: 0009-9147

Subjects--Topical Terms:
Biomarkers--blood
Bone Neoplasms--diagnosis
Glycoproteins--blood
Humans
Male
Middle Aged
Osteoprotegerin
Prostatic Neoplasms--pathology
Receptors, Cytoplasmic and Nuclear--blood
Receptors, Tumor Necrosis Factor

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)